Wayback Machine
Nov DEC Jan
Previous capture 19 Next capture
2014 2015 2016
1 captures
19 Dec 15 - 19 Dec 15
sparklines
Close Help

Summary

New imaging techniques and biomarkers are poised to improve the diagnosis of heart failure. The treatment of heart failure with preserved or reduced ejection fraction remains challenging. New drug treatments under investigation are natriuretic peptides, relaxin, ivabradine, spironolactone, and neprilysin. Stem cell therapy in heart failure is an active area of research.

  • heart failure
  • pulmonary edema
  • nesiritide
  • acute coronary syndrome
  • relaxin
  • preserved ejection fraction
  • I-PRESERVE study
  • brain natriuretic peptide
  • stem cell therapy
  • STEMI, myocardial infarction
  • metaiodobenzylguanidine
  • cardiology & cardiovascular medicine clinical trials
View Full Text